EC Microbiology

Review Article Volume 22 Issue 9 - 2026

Capsules, Fecal Microbiota Transplantation, or Freeze-Drying?

Rodríguez-Flores JR1, Villanueva-Cerda DV2, Chávez-Mora IY3, Dávila-Espinoza GS4, Ramírez-Briones E4, Martínez-Jiménez MA3 and Mireles-Flores S3*

1Department of Veterinary Medicine, University Center for Biological and Agricultural Sciences, University of Guadalajara, Mexico
2Veterinary Medicine Undergraduate Student, University Center for Biological and Agricultural Sciences, University of Guadalajara, Mexico
3Animal Production Department, University Center for Biological and Agricultural Sciences, University of Guadalajara, Mexico
4Department of Cellular and Molecular Biology, University Center for Biological and Agricultural Sciences, University of Guadalajara, Mexico

*Corresponding Author: Álvaro Zamudio Tiburcio, Department of Gastroenterology, Intestinal Microbiota Transplantation, Medical Spe- cialties, Naples Unit, Mexico.
Received: July 27, 2026; Published: August 12, 2026



A comprehensive review of the world literature was conducted to determine which of the three currently available methodologies is the best. All concepts were analyzed when transplanting the gut microbiota from a healthy individual to a patient with pseudomembranous enterocolitis due to Clostridium difficile, irritable bowel syndrome, inflammatory bowel disease, and other disorders.

Keywords: Capsules (Caps); FMT (Fecal Microbiota Transplantation); Lyophilization (Lio)

  1. Ericksen B., et al. “Antibacterial activity and specificity of the six human α-defensins”. Antimicrobial Agents and Chemotherapy 1 (2005): 269-275.
  2. Pazgier M., et al. “Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptide”. Journal of Biological Chemistry 12 (2012): 8944-8953.
  3. Rajabi M., et al. “Functional determinants of human enteric α-defensin HD5: crucial role for hydrophobicity at dimer interface”. Journal of Biological Chemistry26 (2012): 21615-21627.
  4. Wei G., et al. “Through the looking glass, mechanistic insights from enantiomeric human defensins”. Journal of Biological Chemistry 42 (2009): 29180-29192.
  5. Wei G., et al. “Trp-26 imparts functional versatility to human alpha-defensin HNP1”. Journal of Biological Chemistry 21 (2010): 16275-16285.
  6. Wu Z., et al. “Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins?” Journal of Biological Chemistry 52 (2005): 43039-43047.
  7. Wu Z., et al. “Impact of pro segments on the folding and function of human neutrophil alpha-defensins”. Journal of Molecular Biology 2 (2007): 537-549.
  8. Xie C., et al. “Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids”. Journal of Biological Chemistry 38 (2005): 32921-32929.
  9. Xie C., et al. “Effects of the terminal charges in human neutrophil alpha-defensin 2 on its bactericidal and membrane activity”. Peptides 12 (2005): 2377-2383.
  10. Zhao L., et al. “Invariant gly residue is important for α-defensin folding, dimerization, and function: a case study of the human neutrophil α-defensin HNP1”. Journal of Biological Chemistry 23 (2012): 18900-18912.
  11. Zhao L., et al. “Single, double and quadruple alanine substitutions at oligomeric interfaces identify hydrophobicity as the key determinant of human neutrophil alpha defensin HNP1 function”. PLoS One 11 (2013): e78937.
  12. Zou G., et al. “Molecular determinants for the interaction of human neutrophil alpha defensin 1 with its propeptide”. Journal of Molecular Biology 5 (2008): 1281-1291.
  13. Pazgier M., et al. “Structural and functional analysis of the pro-domain of human cathelicidin LL-37”. Biochemistry9 (2013): 1547-1558.
  14. Brook I. “Inoculum effect”. Reviews of Infectious Diseases 3 (1989): 361-368.
  15. Ericksen B., et al. “Virtual colony count”. WikiJSci1 (2020): 3.
  16. Liao C., et al. “Human neutrophil α-defensin HNP1 interacts with bacterial cell wall components to promote biofilm formation by Staphylococcus aureus”. Biofilm 10 (2025): 100338.
  17. Alcouloumre MS., et al. “Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro”. Antimicrobial Agents and Chemotherapy 12 (1993): 2628-2632.
  18. Rubinchik E., et al. “Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonization models”. International Journal of Antimicrobial Agents 5 (2009): 457-461.
  19. McDonnell MJ., et al. “Inhibition of verocytotoxigenic Escherichia coli by antimicrobial peptides caseicin A and B and the factors affecting their antimicrobial activities”. International Journal of Food Microbiology 3 (2012): 260-268.
  20. Snoussi M., et al. “Heterogeneous absorption of antimicrobial peptide LL-37 in Escherichia coli cells enhances population survivability”. eLife 7 (2018): e38174.
  21. Loffredo MR., et al. “Inoculum effect of antimicrobial peptides”. Proceedings of the National Academy of Sciences of the United States of America 21 (2021): e2014364118.
  22. Ikuma K., et al. “The extracellular bastions of bacteria-a biofilm way of life”. Nature Education Knowledge 2 (2013): 2.
  23. Ericksen B. “Quantification of polysaccharides fixed to Gram stained slides using lactophenol cotton blue and digital image processing”. F1000Research 4 (2015): 1.

Álvaro Zamudio Tiburcio., et al. “Capsules, Fecal Microbiota Transplantation, or Freeze-Drying?”. EC Microbiology 22.9 (2026): 01-05.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net